Additionally, research suggests that semaglutide may also reduce A1C levels in people with or without diabetes, making it a dual-purpose treatment [5]
For researchers modeling type 2 diabetes, insulin resistance, or age-related metabolic decline, MOTS-c offers a holistic approach that improves muscle function and overall physical capacity
often used with very low-calorie diets, although not commonly advocated for today
Finally, social media and online patient forums often discuss nutritional concerns related to GLP-1 receptor agonists, sometimes spreading misinformation or conflating different medications and their effects
It also helps prevent the formation of new fat and may improve bone density
The dosage and frequency depend on the severity of the deficiency and the underlying cause